Zhejiang Hisoar Pharmaceutical Co., Ltd.

XSEC:002099 Stock Report

Market Cap: CN¥9.4b

Zhejiang Hisoar Pharmaceutical Balance Sheet Health

Financial Health criteria checks 3/6

Zhejiang Hisoar Pharmaceutical has a total shareholder equity of CN¥5.5B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 20.3%. Its total assets and total liabilities are CN¥7.6B and CN¥2.1B respectively.

Key information

20.3%

Debt to equity ratio

CN¥1.11b

Debt

Interest coverage ration/a
CashCN¥1.48b
EquityCN¥5.46b
Total liabilitiesCN¥2.15b
Total assetsCN¥7.61b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 002099's short term assets (CN¥2.8B) exceed its short term liabilities (CN¥2.1B).

Long Term Liabilities: 002099's short term assets (CN¥2.8B) exceed its long term liabilities (CN¥95.3M).


Debt to Equity History and Analysis

Debt Level: 002099 has more cash than its total debt.

Reducing Debt: 002099's debt to equity ratio has increased from 5.8% to 20.3% over the past 5 years.

Debt Coverage: 002099's debt is not well covered by operating cash flow (12%).

Interest Coverage: Insufficient data to determine if 002099's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies